Autoantibodies against IA-2 have been detected in up to 86% of newly diagno
sed patients with type 1 diabetes and appear to identify a subgroup oi pred
iabetic subjects who rapidly progress to type 1 diabetes. We examined the a
ssociation of IA-2 gene polymorphism with type 1 diabetes in Japanese subje
cts. A total of 276 Japanese subjects were studied fur disease association
and, in addition, another 53 patients were studied for association with the
autoantibody status to IA-2. A microsatellite marker D2S1753E, located in
thr intron of the IA-2 gene, was used as a genetic marker in this study. In
Japanese, two alleles (161mu and 165mu) were more frequent, and the 163mu
allele was less frequent than in Caucasians (p = 0.0001). There was no sign
ificant difference in frequencies of alleles between diabetic patients and
control subjects. The frequency of IA-2 gene polymorphism was not significa
ntly different between patients stratified by age-at-onset, or between pati
ents with and without susceptible HLA, DRB1*0405, DRB1*0802 and DRB1*'0901.
There was no significant difference in allele frequency of the IA-2 gene p
olymorphism between patients with and without autoantibody to IA-2. In conc
lusion, IA-2 gene polymorphism is not associated with either susceptibility
to, or heterogeneity in type 1 diabetes in Japanese subjects. (C) American
Society fur Histocompatibility and Immunogenetics, 2001. Published by Else
vier Science Inc.